Rockwell Medical Begins Second Phase III Clinical Trial for Treatment of Iron ... - GlobeNewsWire (press release) PDF Print
GlobeNewsWire (press release)
Based on the data to date, we believe that SFP provides anemic dialysis patients with a safe, physiologic alternative for iron delivery. We look forward to positive results from the CRUISE studies." Rockwell is conducting two pivotal Phase III clinical

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.